|
🐜
|
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.
19 auth.
M. Aapro,
P. Abrahamsson,
J. Body,
R. Coleman,
R. Colomer,
L. Costa,
L. Crinò,
L. Dirix,
M. Gnant,
J. Gralow,
...
P. Hadji,
G. Hortobagyi,
W. Jonat,
A. Lipton,
A. Monnier,
A. Paterson,
R. Rizzoli,
F. Saad,
B. Thürlimann
|
8 |
2008 |
8
🐜
|
|
🐜
|
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases.
16 auth.
A. Lipton,
G. Steger,
J. Figueroa,
C. Alvarado,
P. Solal-Céligny,
J. Body,
R. De Boer,
R. Berardi,
P. Gascón,
K. Tonkin,
...
R. Coleman,
A. Paterson,
M. Peterson,
M. Fan,
A. Kinsey,
S. Jun
|
8 |
2007 |
8
🐜
|
|
🐜
|
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
11 auth.
J. Body,
R. Bartl,
P. Burckhardt,
P. Delmas,
I. Diel,
HA Fleisch,
...
J. Kanis,
R. Kyle,
G. Mundy,
A. Paterson,
R. Rubens
|
8 |
1998 |
8
🐜
|
|
🐜
|
Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
12 auth.
M. Paterson,
K. Dietrich,
J. Danyluk,
A. Paterson,
A. Lees,
N. Jamil,
...
J. Hanson,
H. Jenkins,
B. Krause,
W. McBlain,
D. Slamon,
R. Fourney
|
8 |
1991 |
8
🐜
|
|
🐜
|
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis.
14 auth.
K. Broglio,
M. Quintana,
M. Foster,
Melissa Olinger,
A. McGlothlin,
S. Berry,
J. Boileau,
C. Brezden-Masley,
S. Chia,
S. Dent,
...
K. Gelmon,
A. Paterson,
D. Rayson,
D. Berry
|
8 |
2016 |
8
🐜
|
|
🐬
|
A high incidence of vertebral fracture in women with breast cancer
J. Kanis,
E. McCloskey,
T. Powles,
A. Paterson,
S. Ashley,
T. Spector
|
7 |
1999 |
7
🐬
|
|
🐜
|
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]
10 auth.
T. Powles,
A. Paterson,
E. McCloskey,
P. Schein,
B. Scheffler,
A. Tidy,
...
S. Ashley,
I. Smith,
L. Ottestad,
J. Kanis
|
7 |
2006 |
7
🐜
|
|
🦁
|
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.
20 auth.
A. Paterson,
S. Anderson,
B. Lembersky,
L. Fehrenbacher,
C. Falkson,
K. King,
L. Weir,
A. Brufsky,
S. Dakhil,
T. Lad,
...
Luis Baez-Diaz,
J. Gralow,
A. Robidoux,
E. Perez,
P. Zheng,
C. Geyer,
S. Swain,
J. Costantino,
E. Mamounas,
N. Wolmark
|
7 |
2012 |
7
🦁
|
|
🐜
|
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.
20 auth.
S. Aebi,
S. Gelber,
S. Anderson,
I. Láng,
A. Robidoux,
Miguel Martín,
J. Nortier,
A. Paterson,
M. Rimawi,
J. B. Cañada,
...
B. Thürlimann,
E. Murray,
E. Mamounas,
C. Geyer,
K. Price,
A. Coates,
R. Gelber,
P. Rastogi,
N. Wolmark,
I. Wapnir
|
7 |
2014 |
7
🐜
|
|
🐜
|
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
19 auth.
A. Stopeck,
K. Fizazi,
J. Body,
Janet E Brown,
M. Carducci,
I. Diel,
Y. Fujiwara,
Miguel Martín,
A. Paterson,
K. Tonkin,
...
N. Shore,
P. Sieber,
F. Kueppers,
L. Karsh,
D. Yardley,
Huei Wang,
T. Maniar,
J. Arellano,
A. Braun
|
7 |
2015 |
7
🐜
|
|
🐜
|
Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy
16 auth.
A. Lipton,
G. Steger,
J. Figueroa,
C. Alvarado,
P. Solal-Céligny,
J. Body,
R. De Boer,
R. Berardi,
P. Gascón,
K. Tonkin,
...
R. Coleman,
A. Paterson,
G. Gao,
A. Kinsey,
M. Peterson,
S. Jun
|
7 |
2008 |
7
🐜
|
